NDC 73352-830
Tridacaine II 50 mg per 1 g patch
On the label: Trifluent Pharma, Inc.. It's repackaged: Trifluent Pharma, Inc. rebottles it from Actavis Pharma, Inc.'s NDC 0591-3525.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Actavis Pharma, Inc. names for other drugs.
Recalls
- Apr 13, 2022 · Class II · Mckesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer. - Jul 14, 2020 · Class II · Teva Pharmaceuticals USA
Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
Lots: Carton Lot # 1383513B, Patch Lot # 1383513, Exp date 03/2022 - Apr 30, 2018 · Class III · Teva Pharmaceuticals USA
Failed Stability Specifications
Lots: Carton Lot Number:1147020B Patch (Envelope) Lot Number: 1147020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lidocaine: every company that makes it
- Form
- patch, topical
- Strength
- 50 mg per 1 g
- Approval
- ANDA ANDA200675
- On the market since
- May 20, 2024
- Package NDCs
73352-830-0173352-830-15- Official label
- DailyMed (National Library of Medicine), updated Jun 12, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?